Companies/InspireMD, Inc.

Company profile

InspireMD, Inc.

NASDAQ: NSPR · Healthcare · Medical - Devices

PublicHQ Miami, CIK 0001433607Reports USD

#646 of 1,402 Healthcare companies by revenue71st-percentile growth

EA Score

50D

FH 42DQ —GM 69SS 62

v0.1 · 45/100 weight · provisional

↑ disclosure history, balance-sheet leverage · ↓ operating margin, net margin

Methodology →

Revenue TTM

$9.0M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$48.8M

Employees

127

Market cap

$33.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$9.0M$9.0M2025

Net income-$48.8M-$48.8M2025

Operating income-$49.6M-$49.6M2025

Total assets$69.4M$69.4M2025

Liabilities$14.2M$14.2M2025

Equity$55.2M$55.2M2025

Revenue trend

FY2018 – FY2025 · USD

$3.6M

FY18

$3.7M

FY19

$2.5M

FY20

$4.5M

FY21

$5.2M

FY22

$6.2M

FY23

$7.0M

FY24

$9.0M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

InspireMD, Inc. booked $9.0M in FY2025 revenue, growing 28% year over year — faster than most Healthcare companies we track, at a -543.3% net margin.

Peers · Healthcare

Vaso Corporation68B LeonaBio, Inc.——MedMira Inc.31D RenovoRx, Inc.32D

Key facts

CEOMarvin L. Slosman

SectorHealthcare

IndustryMedical - Devices

HeadquartersMiami, null

ExchangeNASDAQ: NSPR

Employees127

IPO date2011-04-12

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.